<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Shuang Li - Research Publications</title>
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lato">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        body {
            font-family: 'Lato', sans-serif;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            line-height: 1.6;
            color: #333;
            margin: 0;
            padding: 0;
        }
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        .navbar {
            background-color: #ffffff;
            border-bottom: 1px solid #e7e7e7;
            padding: 10px 0;
            position: sticky;
            top: 0;
            z-index: 1000;
        }
        .navbar-nav {
            list-style-type: none;
            padding: 0;
            margin: 0;
            display: flex;
            justify-content: center;
        }
        .navbar-nav li {
            margin: 0 15px;
        }
        .navbar-nav a {
            color: #666666;
            text-decoration: none;
            font-weight: bold;
            font-size: 18px;
        }
        h1, h2, h3, h4 {
            color: #1a5f7a;
        }
        main {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        .paper {
            background-color: #ffffff;
            border-radius: 8px;
            box-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
            margin-bottom: 30px;
            padding: 20px;
        }
        .paper-title {
            font-size: 1.5em;
            margin-bottom: 10px;
        }
        .paper-links {
            margin-bottom: 20px;
        }
        .button {
            display: inline-block;
            padding: 8px 16px;
            margin-right: 10px;
            background-color: #1a5f7a;
            color: #ffffff;
            text-decoration: none;
            border-radius: 4px;
            font-size: 14px;
        }
        .paper-details {
            display: flex;
            flex-wrap: wrap;
            gap: 20px;
        }
        .paper-content {
            flex: 1;
            min-width: 300px;
        }
        .paper-content h3 {
            color: #1a5f7a;
            margin-top: 20px;
            margin-bottom: 10px;
        }
        .paper-content p {
            line-height: 1.8;
            text-align: justify;
        }
        .paper-content ul {
            line-height: 1.8;
        }
        footer {
            text-align: center;
            padding: 20px;
            background-color: #f5f7fa;
            margin-top: 40px;
        }
    </style>
</head>
<body>
    <nav class="navbar">
        <div class="container">
            <ul class="navbar-nav">
                <li><a href="/">Home</a></li>
                <li><a href="/publication/">Research</a></li>
            </ul>
        </div>
    </nav>

    <main>
        <h1>Research Publications</h1>

        <!-- Conference Poster Section -->
        <div class="paper" style="background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-left: 4px solid #e67e22;">
            <h2 class="paper-title">Conference Poster</h2>
            <p><strong>Li S</strong> - Research Poster Presentation</p>
            
            <div class="paper-links">
                <a href="../Poster.pdf" class="button" target="_blank">ðŸ“Š View Poster (PDF)</a>
            </div>

            <div class="paper-content">
                <div style="text-align: center; margin-top: 20px;">
                    <embed src="../Poster.pdf" type="application/pdf" width="100%" height="800px" style="border: 2px solid #ddd; border-radius: 8px;" title="Research Poster by Shuang Li" aria-label="Conference poster presentation by Shuang Li" />
                    <p style="margin-top: 10px; font-style: italic; color: #666;">
                        <a href="../Poster.pdf" target="_blank">Click here if the poster doesn't display</a>
                    </p>
                </div>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Serpin B9 Controls Tumor Cell Killing by CAR T Cells</h2>
            <p>Kimman T, Slomp A, Martens A, Grabherr S, <strong>Li S</strong>, van Diest E, et al.</p>
            <p><em>J Immunother Cancer.</em> 2023 Mar 31;11(3):e006370.</p>

            <div class="paper-links">
                <a href="https://pubmed.ncbi.nlm.nih.gov/36931661/" class="button">ðŸ“„ Read Paper</a>
                <a href="https://jitc.bmj.com/" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Summary:</h3>
                <p>This study investigates the role of Serpin B9, a granzyme B inhibitor, in controlling tumor cell killing by CAR T cells. The research demonstrates how Serpin B9 expression in tumor cells can protect them from CAR T cell-mediated cytotoxicity, providing insights into mechanisms of resistance to CAR T cell therapy and potential strategies to improve therapeutic efficacy.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Pediatric Medulloblastoma Express Immune Checkpoint B7-H3</h2>
            <p><strong>Li S</strong>, Poolen G, van Vliet L, et al.</p>
            <p><em>Clin Transl Oncol.</em> 2022 Jan 5;24(6):1204-1208.</p>

            <div class="paper-links">
                <a href="https://doi.org/10.1007/s12094-021-02762-y" class="button">ðŸ“„ Read Paper</a>
                <a href="https://link.springer.com/journal/12094" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Summary:</h3>
                <p>This research validates the expression of immune checkpoint B7-H3 in pediatric medulloblastoma samples, identifying it as a potential therapeutic target for immunotherapy. The study demonstrates that B7-H3 is highly expressed in medulloblastoma tissues, suggesting new opportunities for developing targeted immunotherapies for pediatric brain tumor patients.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives</h2>
            <p>Voskamp MJâ€ , <strong>Li Sâ€ </strong>, van Daalen KR, et al.</p>
            <p><em>Cancers.</em> 2021 Oct 27;13(21):5387.</p>
            <p style="font-style: italic; color: #666;">(â€ Co-first author)</p>

            <div class="paper-links">
                <a href="https://doi.org/10.3390/cancers13215387" class="button">ðŸ“„ Read Paper</a>
                <a href="https://www.mdpi.com/journal/cancers" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Summary:</h3>
                <p>This comprehensive review examines the current state of immunotherapy research in medulloblastoma, discussing key challenges and future perspectives. The review covers various immunotherapeutic approaches including checkpoint inhibitors, CAR-T cell therapy, and vaccine-based strategies, providing insights into the potential and limitations of immunotherapy for this pediatric brain tumor.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Extracellular Granzyme K Modulates Angiogenesis by Regulating Soluble VEGFR1 Release From Endothelial Cells</h2>
            <p><strong>Li S</strong>, van Dijk CGM, Meeldijk J, et al.</p>
            <p><em>Front Oncol.</em> 2021 Jun 8;11:681967.</p>

            <div class="paper-links">
                <a href="https://doi.org/10.3389/fonc.2021.681967" class="button">ðŸ“„ Read Paper</a>
                <a href="https://www.frontiersin.org/journals/oncology" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Summary:</h3>
                <p>This study investigates how extracellular Granzyme K modulates angiogenesis through the regulation of soluble VEGFR1 release from endothelial cells. Using CRISPR knockout models and flow cytometry, the research reveals novel mechanisms of granzyme-mediated angiogenesis regulation, providing insights into potential therapeutic targets for anti-angiogenic therapies in cancer.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Killer Cell Proteases Can Target Viral Immediate-Early Proteins to Control Human Cytomegalovirus Infection in a Noncytotoxic Manner</h2>
            <p>Shan L, <strong>Li S</strong>, Meeldijk J, Blijenberg B, et al.</p>
            <p><em>PLOS Pathogens.</em> 2020 Apr 13.</p>

            <div class="paper-links">
                <a href="https://journals.plos.org/plospathogens/" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Summary:</h3>
                <p>This research demonstrates that killer cell proteases (granzymes) can target viral immediate-early proteins to control human cytomegalovirus (HCMV) infection through noncytotoxic mechanisms. The study reveals a novel antiviral function of granzymes beyond their traditional role in inducing cell death, showing how immune cells can control viral infections while preserving infected cells.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">A Novel C Type CpG Oligodeoxynucleotide Exhibits Immunostimulatory Activity In Vitro and Enhances Antitumor Effect In Vivo</h2>
            <p>Li T, Wu J, Zhu S, Zang G, <strong>Li S</strong>, Lv X, et al.</p>
            <p><em>Front Pharmacol.</em> 2020 Feb 6.</p>

            <div class="paper-links">
                <a href="https://www.frontiersin.org/journals/pharmacology" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Summary:</h3>
                <p>This study characterizes a novel C-type CpG oligodeoxynucleotide (ODN) that exhibits potent immunostimulatory activity. The research demonstrates that this CpG ODN activates immune cells in vitro and enhances antitumor effects in vivo, presenting a promising approach for cancer immunotherapy through toll-like receptor (TLR) activation.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Noninvasive Optical Detection of Granzyme B from Natural Killer Cells Using Enzyme-Activated Fluorogenic Probes</h2>
            <p>Janiszewski T, KoÅ‚t S, Kaiserman D, Snipas S, <strong>Li S</strong>, et al.</p>
            <p><em>bioRxiv.</em> 2019 Dec 17.</p>

            <div class="paper-links">
                <a href="https://www.biorxiv.org/" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Summary:</h3>
                <p>This study presents a novel noninvasive optical detection method for measuring Granzyme B activity from natural killer (NK) cells using enzyme-activated fluorogenic probes. The research provides a valuable tool for real-time monitoring of NK cell cytotoxic activity, enabling better understanding of immune cell function and potential applications in immunotherapy monitoring.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG</h2>
            <p>Wu J, <strong>Li S</strong>, Li T, Lv X, et al.</p>
            <p><em>J Immunol Res.</em> 2019 Apr 9.</p>

            <div class="paper-links">
                <a href="https://www.hindawi.com/journals/jir/" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Summary:</h3>
                <p>This study compares the activation of plasmacytoid dendritic cells (pDCs) by different toll-like receptor (TLR) ligands: TLR7/8 ligand CL097, TLR7 ligand IMQ, and TLR9 ligand CpG. The research provides insights into differential pDC activation patterns and cytokine production profiles, informing strategies for optimizing immune stimulation in therapeutic applications.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Disease-Associated Plasmacytoid Dendritic Cells</h2>
            <p><strong>Li S</strong>, Wu J, Zhu S, Liu YJ, Chen J.</p>
            <p><em>Front Immunol.</em> 2017 Oct 16;8:1268.</p>

            <div class="paper-links">
                <a href="https://doi.org/10.3389/fimmu.2017.01268" class="button">ðŸ“„ Read Paper</a>
                <a href="https://www.frontiersin.org/journals/immunology" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Summary:</h3>
                <p>This comprehensive review examines disease-associated plasmacytoid dendritic cells (pDCs) and their roles in various disease contexts. The study provides insights into pDC biology, their activation mechanisms through toll-like receptors, and their involvement in breast cancer, autoimmune diseases, and viral infections, highlighting both protective and pathogenic roles of pDCs.</p>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">TLR-Activated Plasmacytoid Dendritic Cells Inhibit Breast Cancer Cell Growth In Vitro and In Vivo</h2>
            <p><strong>Li S</strong>, et al.</p>
            <p><em>Oncotarget.</em> 2017 Feb 14.</p>

            <div class="paper-links">
                <a href="https://www.oncotarget.com/" class="button">Journal</a>
            </div>

            <div class="paper-content">
                <h3>Summary:</h3>
                <p>This study demonstrates that TLR-activated plasmacytoid dendritic cells (pDCs) can inhibit breast cancer cell growth both in vitro and in vivo. The research reveals mechanisms by which activated pDCs exert anti-tumor effects, providing evidence for the therapeutic potential of pDC-based immunotherapy approaches in breast cancer treatment.</p>
            </div>
        </div>
    </main>

    <footer>
        <p>Â© 2025 Shuang Li. All rights reserved.</p>
    </footer>
</body>
</html>
